Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
03/2003
03/26/2003EP1294383A2 Oral compositions comprising antimicrobial agents
03/26/2003EP1294378A2 Thrombopoietin mimetics
03/26/2003EP1294377A2 Methods and compositions for the treatment of alcoholism and alcohol dependence
03/26/2003EP1294371A1 Medium chain fatty acids applicable as antimicrobial agents
03/26/2003EP1294367A2 Oral compositions comprising host-response modulating agent
03/26/2003EP1294366A1 Pharmaceutical compounds for treating copd
03/26/2003EP1294227A2 Transgenic mice containing nuclear hormone receptor gene disruptions
03/26/2003EP1263466A4 Methods and compositions for dietary supplements
03/26/2003EP1146873A4 Anti-androgens and methods for treating disease
03/26/2003EP1128725B1 Disposable premoistened wipe containing an antimicrobial protease inhibitor
03/26/2003EP1124559B1 Compositions for the treatment and prevention of neurological and pathopsychological diseases
03/26/2003EP1098631B1 Pharmaceutical composition in particular for preventing and treating mucositis induced by radiotherapy or chemotherapy
03/26/2003EP1086249B1 Diagnostic method based on quantification of extramitochondrial dna
03/26/2003EP1083906A4 Aminosugar, glycosaminoglycan, and s-adenosylmethionine composition for the treatment and repair of connective tissue
03/26/2003EP0939809B1 Tie-2 receptor ligand (tie ligand-4) and its use
03/26/2003EP0877599B1 Sustained delivery of leuprolide using an implantable system
03/26/2003EP0804229B1 Use of amlodipine, a salt thereof or felodipin in combination with an ace inhibitor in the manufacture of a medicament for the treatment of nonischemic congestive heart failure
03/26/2003CN1406233A Medicine for viral diseases
03/26/2003CN1406137A Caspase activated prodrugs therapy
03/26/2003CN1406136A Novel antibody with specificity for colon cancer
03/26/2003CN1406132A Method for treating or inhibiting cellular injury or cell death
03/26/2003CN1406129A Methods for the treatment of substance abuse
03/26/2003CN1406128A Use of central cannabinoid receptor antagonist for preparing medicines designed to facilitate smoking cessation
03/26/2003CN1406125A Method for transdermal or intradermal delivery of molecules
03/26/2003CN1404828A Use of pantethine sulfonic acid and/or its salt as free radical scavenger
03/26/2003CN1103780C Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents
03/26/2003CN1103589C Method for modulating human sexual response
03/25/2003WO2003000254A1 Fused cyclic compounds and medicinal use thereof
03/25/2003USRE38046 (delayed type sensitivity) DTH-Effector cells are printed with carbohydrate antigens; antitumor
03/25/2003US6538174 Animal model for transplantation
03/25/2003US6538144 P-thienylbenzylamides as agonists of angiotensin-(1-7) receptors, and methods of their preparation and use
03/25/2003US6538106 Compositions and methods for treating infections using analogues of indolicidin
03/25/2003US6538038 A method of treating a warm-blooded animal having a vascular proliferative disorder, comprising administering, to the animal, an amount of a prodrug of a tubulin binding agent, other than combretastatin A4 disodium phosphate to achieve
03/25/2003US6538037 Inhibiting the hyperproliferation of malignant or neoplastic cells by treating the cells with an antiproliferative amount of 1 alpha ,24(S)-dihydroxyvitamin D2 the cells being cancers of the lung, neck and head, pancreas, endometrium, bladder
03/25/2003US6538036 Method for preventing and treating peripheral neuropathy by administering selegiline
03/25/2003US6538034 Methods of treating or preventing weight gain, obesity, and related disorders
03/25/2003US6538026 A composition comprising of a monomer component comprised of at least one alkyl cyanoacrylate and at least one inhibitor, and a second component comprised of a resultant aggregate structure formed from an alkyl cyanoacrylate monomer, an alkyl
03/25/2003US6538008 Combination of a selective NMDA NR2B antagonist and an opioid analgesic
03/25/2003US6537993 Compounds for enhancing chemotherapy
03/25/2003US6537991 A method of treating a peripheral neuropathic pain in a warm-blooded animal requiring such treatment which comprises administering to said animal a therapeutically effective amount of an EP1-type prostaglandin receptor antagonist
03/25/2003US6537990 Combined preparations comprising morpholine anthracyclines and anticancer agent
03/25/2003US6537988 Synergistic methods and compositions for treating cancer
03/25/2003US6537985 Antibiotic formulation and a method of making this formulation
03/25/2003US6537984 Contacting a targeted solid tumor cell population with a combination of a vinca alkaloid selected from vinblastine, vincristine, vinorelbine, and a triptolide in combination dosage to reduce the targeted tumor cell population
03/25/2003US6537983 Anti-inflammatory androstane derivatives
03/25/2003US6537982 Method of treating prostatic diseases using active vitamin D analogues
03/25/2003US6537977 Anti-inflammatory agent
03/25/2003US6537976 Dialysis solutions containing water soluble vitamins and nutrients
03/25/2003US6537970 The invention relates to a novel pharmaceutical combination comprising clindamycin and clotrimazole for use for vaginal infections.
03/25/2003US6537969 Nutritional supplement for cerebral metabolic insufficiencies
03/25/2003US6537820 Method for producing purified hematinic iron-saccharidic complex and product produced
03/25/2003US6537765 GPR10 as a target for identifying weight modulating compounds
03/25/2003US6537593 Plant phenol as new hepatoprotective agents
03/25/2003US6537585 Methods and compositions for treating solid tumors
03/25/2003US6537581 Compositions and methods for treating eye discomfort
03/25/2003US6537555 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection
03/25/2003US6537545 Use of corneal hardening agents in enzymeorthokeratology
03/25/2003US6537540 Administering recombinant adeno-associated virus vector; polynucleotide encoding fusion polypeptide with extracellular domain of the TNF receptor and a constant domain of an IgG1 molecule
03/25/2003US6537265 Method for nasal application of a medicinal substance
03/25/2003US6537203 Cardiac disease treatment and device
03/25/2003US6536450 Fluid heating system for processing semiconductor materials
03/25/2003CA2423800A1 Fused cyclic compounds and medicinal use thereof
03/25/2003CA2270841C Compositions with analgesic, antipyretic and antiinflammatory properties
03/25/2003CA2088370C New use of monoclonal antibody
03/25/2003CA2065496C Treatment of aphthous ulcers and other mucocutaneous disorders
03/20/2003WO2003023472A1 Source wavelength shifting apparatus and method for delivery of one or more selected emission wavelengths
03/20/2003WO2003023407A1 Methods of screening molecules that are used to prevent cardiovascular diseases
03/20/2003WO2003023405A1 Diagnostic and therapeutic use of f-box proteins for alzheimer's disease and related neurodegenerative disorders
03/20/2003WO2003023404A1 A method of diagnosis and treatment and agents useful for same
03/20/2003WO2003023066A1 Expression profiling in the intact human heart
03/20/2003WO2003023054A1 New assay for inhibitors of translocases
03/20/2003WO2003023048A2 METHODS FOR DIAGNOSING AND TREATING DISEASES AND CONDITIONS ASSOCIATED WITH PROTEIN KINASE C$g(l)
03/20/2003WO2003023028A1 Fungal glyoxal oxidases
03/20/2003WO2003023008A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
03/20/2003WO2003022995A2 Nucleic acid and corresponding protein entitled steap-1 useful in treatment and detection of cancer
03/20/2003WO2003022882A2 Method of increasing the contractility of a heart, a heart muscle or cells of a heart muscle
03/20/2003WO2003022877A1 Crystal structure of baff, and use thereof in drug design
03/20/2003WO2003022852A2 Furo-and thienopyrimidine derivatives as angiogenesis inhibitors
03/20/2003WO2003022830A1 Benzothiepine ileal bile acid transport inhibitors
03/20/2003WO2003022825A1 Benzothiazepine derivatives for the treatment of hyperlipidemia
03/20/2003WO2003022360A2 Thermotherapy via targeted delivery of nanoscale magnetic particles
03/20/2003WO2003022310A1 Prostaglandin compositions and methods of treatment for male erectile dysfunction
03/20/2003WO2003022305A1 Method for treating coumarin-induced hemorrhage
03/20/2003WO2003022299A1 Genobix agonists and antagonists for use in the treatment of metabolic disorders
03/20/2003WO2003022296A1 Method and composition for treating immune complex associated disorders
03/20/2003WO2003022291A1 Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect
03/20/2003WO2003022284A1 Methods of treating pulmonary disease
03/20/2003WO2003022283A1 Combination of an adenosine a2a receptor antagonist and an antidepressant or anxiolytic
03/20/2003WO2003022282A1 Use of 4-pyridylmethylphthalazines for cancer treatment
03/20/2003WO2003022271A1 Lymphocytic activation inhibitor and remedial agent for autoimmune disease
03/20/2003WO2003022268A1 A combination and method of treatment of cancer utilizing a cox-2 inhibitor and a 3-hydroxy-3-methylglutaryl-coenzyme-a (hmg-coa) reductase inhibitor
03/20/2003WO2003022258A1 Aryloxypropylamines as chemosensitizing agent in the treatment of cancer
03/20/2003WO2003022246A1 Treating effects of excessive reactive oxygen species
03/20/2003WO2003022244A1 Vascular occlusion solid-phase agent with immobilised platelet binding agent
03/20/2003WO2003022218A2 Carboxylate-gated-nitroxide (cgn) compounds and compositions and methods of use thereof
03/20/2003WO2003022217A2 Treatment of excessive radiation (e.g. sunburn) exposure
03/20/2003WO2003022215A2 Compositions and methods for priming monocytic dendritic cells and t cells for th-1 response
03/20/2003WO2003022207A2 Method and composition for reducing sebum secretion in mammals
03/20/2003WO2003022192A1 Eustachian tube stent
03/20/2003WO2003022123A2 Methods of kidney transplantation utilizing developing nephric tissue
1 ... 725 726 727 728 729 730 731 732 733 734 735 736 737 738 739 740 741 742 743 744 745 ... 1151